OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC...

Journal of Thoracic Oncology 2019 / 10 Vol. 14; Iss. 10

OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3

Oezkan, F., He, K., Owen, D., Pietrzak, M., Cho, J.H., Kitzler, R., Pearson, R., Rusch, V., Chaft, J., Suh, R., Blasberg, J., Reckamp, K., Raz, D., Kneuertz, P., Fiorillo, L., Garon, E., Nicholas, A.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.482
Date:
October, 2019
File:
PDF, 494 KB
2019
Conversion to is in progress
Conversion to is failed